Celldex Therapeutics | CLDX - Assets

Stock Price
30.08
Daily Change
1.54 5.40%
Monthly
30.67%
Yearly
51.31%
Q1 Forecast
28.62

Celldex Therapeutics reported $582.98M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Agenus USD 226.8M 7.09M Dec/2025
Amgen USD 90.59B 445M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Celldex Therapeutics USD 582.98M 65.46M Dec/2025
Glaxosmithkline GBP 82.34B 102.25M Dec/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Northwest Biotherapeutics USD 30.61M 1.06M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Rigel Pharmaceuticals USD 242.53M 35.8M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025